High Note Wealth’s Idexx Laboratories IDXX Stock Holding History

High Note Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.74K	Buy	12 +3	+33%	+$1.92K	﹤0.01%	446
2025 Q4	$6.09K	Buy	9 +2	+29%	+$1.36K	﹤0.01%	438
2025 Q3	$4.47K	Hold	7	–	–	﹤0.01%	520
2025 Q2	$3.75K	Buy	7 +3	+75%	+$1.44K	﹤0.01%	555
2025 Q1	$1.68K	Buy	+4	New	+$1.74K	﹤0.01%	700

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

High Note Wealth's IDXX Position: Q1 2026 in Review

High Note Wealth increased its Idexx Laboratories (IDXX) stake by 33% in Q1 2026, buying an estimated $1.92K and bringing the position to 12 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

High Note Wealth first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

High Note Wealth held 12 shares of Idexx Laboratories worth $6.74K as of Q1 2026.
High Note Wealth bought 3 Idexx Laboratories shares in Q1 2026, an estimated $1.92K.
Idexx Laboratories made up ﹤0.01% of High Note Wealth's portfolio in Q1 2026, its #446 holding.
High Note Wealth first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.